The Respiratory Group at The George Institute undertakes clinical studies in chronic lung diseases, especially those affecting the airways, such as Asthma and Chronic Obstructive Pulmonary Disease (COPD, also known as chronic bronchitis and emphysema). The group is led by Professor Christine Jenkins.
Christine Jenkins is a thoracic physician with wide experience and skills in undertaking respiratory trials, and in trial methodology, design and interpretation. She is Professor, Respiratory Medicine at UNSW Sydney, and Clinical Professor, Concord Clinical School, University of Sydney. Her research interests in respiratory medicine are underpinned by a practical focus on delivering better quality care to people with lung disease, especially asthma and COPD. She has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease.
These studies have a strong focus on gathering evidence for best practice and to the translation of research findings into practice, especially through guidelines, clinical tools and education. In her role at The George Institute she supervises a research team and PhD students, implementing several trials in asthma, COPD, breathlessness and pulmonary rehabilitation in Australia, New Zealand and Asia. She is active in advocacy and leadership for lung health in Australia and is a member of several global advisory boards for the pharmaceutical industry. In recognition of this commitment, was made a Member of the Order of Australia for services to respiratory medicine as a physician, administrator and educator, especially in the field of asthma education. She is the current Chair of the Board of the Lung Foundation of Australia, the peak body for lung health in Australia.
Click here for more information about our work on respiratory trials with George Clinical.